Cargando…

TGFBI Promoter Methylation is Associated with Poor Prognosis in Lung Adenocarcinoma Patients

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide and has high rates of metastasis. Transforming growth factor beta-inducible protein (TGFBI) is an extracellular matrix component involved in tumour growth and metastasis. However, the exact role of TGFBI in NS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seok, Yangki, Lee, Won Kee, Park, Jae Yong, Kim, Dong Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399005/ https://www.ncbi.nlm.nih.gov/pubmed/30726660 http://dx.doi.org/10.14348/molcells.2018.0322

Ejemplares similares

Promoter methylation of Wrap53α, an antisense transcript of p53, is associated with the poor prognosis of patients with non-small cell lung cancer
por: Kim, Dong Sun, et al.
Publicado: (2018)

TGFBI Promotes Tumor Growth and is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Bing-jie, et al.
Publicado: (2019)

Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR
por: Shah, Jinesh N, et al.
Publicado: (2008)

Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
por: Yun, Sumi, et al.
Publicado: (2016)

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma
por: Wei, Dong, et al.
Publicado: (2023)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

Pan-Cancer Analysis of the Associations of TGFBI Expression With Prognosis and Immune Characteristics
por: Chen, Yun, et al.
Publicado: (2021)

CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
por: He, Jian, et al.
Publicado: (2023)

CIP4 Promotes Lung Adenocarcinoma Metastasis and Is Associated with Poor Prognosis
por: Truesdell, P, et al.
Publicado: (2014)

Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2018)

Extent of visceral pleural invasion and the prognosis of surgically resected node‐negative non‐small cell lung cancer
por: Seok, Yangki, et al.
Publicado: (2017)

Mutation Analysis of the TGFBI Gene in Consecutive Korean Patients With Corneal Dystrophies
por: Song, Ju Sun, et al.
Publicado: (2015)

IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation
por: Smith, E, et al.
Publicado: (2014)

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
por: Wang, Ning, et al.
Publicado: (2012)

TGFBI modulates tumour hypoxia and promotes breast cancer metastasis
por: Fico, Flavia, et al.
Publicado: (2020)

TGFBI gene mutations in a Korean population with corneal dystrophy
por: Cho, Kyong Jin, et al.
Publicado: (2012)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma
por: Choi, Sun Ha, et al.
Publicado: (2020)

PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
por: Tang, Suping, et al.
Publicado: (2022)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2023)

The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology
por: Lee, Soyeon, et al.
Publicado: (2016)

Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma
por: Wu, Moxin, et al.
Publicado: (2020)

Hypermethylation of normal mucosa of esophagus-specific 1 is associated with an unfavorable prognosis in patients with non-small cell lung cancer
por: Kim, Dong Sun, et al.
Publicado: (2018)

Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma
por: Li, Dong, et al.
Publicado: (2020)

Linc00152 promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung adenocarcinoma
por: Zhang, Pei-pei, et al.
Publicado: (2017)

SKA3 Up-regulation Promotes Lung Adenocarcinoma Growth and is a Predictor of Poor Prognosis
por: Sun, Rong-Li, et al.
Publicado: (2019)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
por: Wang, Jingshu, et al.
Publicado: (2017)

Genetic variants in histone modification regions are associated with the prognosis of lung adenocarcinoma
por: Kang, Hyo-Gyoung, et al.
Publicado: (2021)

TGFBI remodels adipose metabolism by regulating the Notch-1 signaling pathway
por: Lee, Seul Gi, et al.
Publicado: (2023)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma
por: Chang, Sisi, et al.
Publicado: (2021)

Synchrotron Radiation-Based Refraction-Contrast Tomographic Images Using X-ray Dark-Field Imaging Optics in Human Lung Adenocarcinoma and Histologic Correlations
por: Yi, Eunjue, et al.
Publicado: (2021)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma
por: Fu, Tao, et al.
Publicado: (2016)

Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients
por: Shi, Shanping, et al.
Publicado: (2020)

Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma
por: Hong, Mi Jeong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ja9tkgnbq5otc3ebhvns3n1k7b